Enterprise Therapeutics Ltd
09022750
Some Concerns
- Negative net worth (-10)
- Loss before tax (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 03/11/2016
CEO
BRITISH · UNITED KINGDOM · Age 51
Also on 2 other boards
secretary · Since 15/12/2016
Persons with Significant Control
Enterprise Therapeutics Holdings Limited
Sussex Innovation Centre Science Park Square, Falmer, Brighton, BN1 9SB
Reg: 12868901 · Companies House · Corporate
Notified 05/10/2020
Former PSCs
Touchstone Innovations Businesses Llp
Ceased 05/10/2020
Epidarex Capital Partners Limited
Ceased 06/04/2018
Ip2ipo Portfolio (Gp) Limited
Ceased 05/10/2020
Charges0 outstanding
SILICON VALLEY BANK
CompanyRankvs 1932+ SIC 72110 peers33
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
been prepared in accordance with IFRS as adopted by the UK , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless the Director either intend s to liquidate the Company or to cease ope
Key FinancialsYear ending 30/06/2025
Net Worth
-£17.2M
Balance sheet strength
Cash
—
Cash in the bank
Profit Before Tax
-£5.3M
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
£7.2M
Current Liabilities
£24.5M
Admin Expenses
£5.3M
Operating Profit
-£5.3M
Profit After Tax
-£4.3M
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.30 | -£4.3M |
| 2024 | 0.44 | -£14.8M |
| 2021 | — | -£4.2M |
Derived from filed accounts. Not audited figures.